When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   Additionally, by the fourth week of the study, 22.5% of participants taking 84 milligram (mg) doses of Spravato achieved MDD remission with an MADRS total score of less than or equal to 12, and 18 ...

3. Esketamine - Wikipedia

   en.wikipedia.org/wiki/Esketamine

   Esketamine, sold under the brand names Spravato (for depression) and Ketanest (for anesthesia) among others, [10] [12] is the S(+) enantiomer of ketamine. [5] [13] It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression.

4. Dissociation (psychology) - Wikipedia

   en.wikipedia.org/wiki/Dissociation_(psychology)

   Dissociation is commonly displayed on a continuum. [18] In mild cases, dissociation can be regarded as a coping mechanism or defense mechanism in seeking to master, minimize or tolerate stress – including boredom or conflict. [19] [20] [21] At the non-pathological end of the continuum, dissociation describes common events such as daydreaming.

5. Dissociative disorder - Wikipedia

   en.wikipedia.org/wiki/Dissociative_disorder

   A second area of discussion surrounds the question of whether there is a qualitative or quantitative difference between dissociation as a defense versus pathological dissociation. Experiences and symptoms of dissociation can range from the more mundane to those associated with post traumatic stress disorder (PTSD) or acute stress disorder (ASD ...

6. Does Medicare cover ketamine infusions for mental health ...

   www.aol.com/does-medicare-cover-ketamine...

   Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.

7. Ketamine-assisted psychotherapy - Wikipedia

   en.wikipedia.org/wiki/Ketamine-assisted...

   Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]